Home/Top cited articles

Top cited articles

Acceptance rate:
50%
Time to first decision with review:
45 days*
Time from acceptance to publication:
25 days*
Impact Factor:
2.7
Citescore:
4.0
Citescore rank:
136/354
Acute myocarditis caused by COVID-19 disease and following COVID-19 vaccination Lipoprotein(a) levels in a global population with established atherosclerotic cardiovascular disease Nutraceutical activation of Sirt1: a review Effects of exercise-based cardiac rehabilitation delivery modes on exercise capacity and health-related quality of life in heart failure: a systematic review and network meta-analysis Role of artificial intelligence in defibrillators: a narrative review Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes Valvular disease burden in the modern era of percutaneous and surgical interventions: the UK Biobank Impact of dapagliflozin treatment on renal function and diuretics use in acute heart failure: a pilot study Copper chelation in patients with hypertrophic cardiomyopathy Risk of atrial fibrillation and stroke among older men exposed to prolonged endurance sport practice: a 10-year follow-up. The Birkebeiner Ageing Study and the Tromso Study Predicting outcomes in patients with aortic stenosis using machine learning: the Aortic Stenosis Risk (ASteRisk) score Modified Duke/European Society of Cardiology 2015 clinical criteria for infective endocarditis: time for an update? Prospective arrhythmia surveillance after a COVID-19 diagnosis External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland Cardiac postacute sequelae symptoms of SARS-CoV-2 in community-dwelling adults: cross-sectional study Cost-effectiveness in diagnosis of stable angina patients: a decision-analytical modelling approach Peak troponin T in STEMI: a predictor of all-cause mortality and left ventricular function Uncovering the treatable burden of severe aortic stenosis in the UK Lipid lowering with inclisiran: a real-world single-centre experience